Health Care: Drugs

Clovis Oncology Inc (CLVS: NASDAQ)

$90.6 n/a | n/a%
05/28/15 - 03:59 PM ET
Latest Dividend:0
Latest Dividend Yield:0%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
CLVSSector Avg.S&P 500
n/a026.97
Price Performance History (% change):
3 Mo1 Yr3 Yr
18.493384.9735388.4097
GROWTH12 Mo3 YrCAGR
Revenue00
Net Income1.880
EPS-0.67n/a
Earnings for CLVS:
EBITDA-145.00
REVENUE13.63M
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $-2.16 $-2.28 $-8.39 $-8.21
Number of Analysts 3 3 4 4
High Estimate $-2.06 $-1.90 $-7.85 $-6.13
Low Estimate $-2.30 $-2.57 $-9.01 $-10.38
Prior Year $-1.03 $-1.17 $-4.72 $-8.39
Growth Rate (Year over Year) -109.71% -94.87% -77.75% 2.18%

Portfolios with CLVS

Latest CLVS Headlines from TheStreet

More Financial News for CLVS

Press Releases for CLVS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter